QOF review committee criticised over choice of indicators
By Tom Moberly, 08 September 2009
NICE's QOF review committee is facing criticism for proposing indicators with too little evidence of effectiveness, while rejecting others well supported by evidence.
NICE acknowledged earlier this year that poor evidence on cost-effectiveness would limit its ability to review indicators.
Much of the evidence used to assess them so far has been merely expert opinion, according to QOF statistics expert and Wiltshire GP Dr Gavin Jamie.
The review committee was ‘pretty scathing' about even the indicators it chose to put forward for negotiation, Dr Jamie said. Many other indicator proposals from charities and other organisations were ‘sent back for more work'.
Poor evidence has been a particular problem for cost-effectiveness assessments, Dr Jamie believes. ‘The cost-effectiveness documents are a bit of a disaster,' he said. ‘In the new epilepsy indicator there is no cost-benefit evidence offered and it is pretty thin for the Down's TSH indicator,' he said.
NICE documents acknowledge that cost-effectiveness evidence is 'modest' for the epilepsy indicator and that no such evidence is available for the Down's syndrome indicator.
- Read the full story in this week's GP dated 11 September.
Related links
Additional Information

Latest jobs Jobs web feed
- 2X Part Time Salaried GPs Deerness Park Medical Centre Competitive, Sunderland Tyne & Wear
- Full time GP partner - Isle of Man Laxey and Village Walk Health Centres Competitive, Isle of Man
- A&E Specialty Doctors Hays Healthcare £36000.00 - £68000.00 per annum, London
- GP Locum in Dorset - Short Term Locum Fresh Medical Recruitment £70 per hour, Dorset
- GP Locum in North London - Weekday Shifts Fresh Medical Recruitment £70 per hour, London
- Consultant A&E Doctors Hays Healthcare £74000.00 - £100000.00 per annum, London
Most read
- NHS reforms: Interactive Health Bill timeline
- Clinical Quiz on GPonline.com
- CMOs issue vitamin D warning to GPs
- RCGP demands withdrawal of Health Bill in letter to PM
- BMA leaders call for Lansley to quit as Lords prepare to debate reforms
- England's CMO issues cold snap warning to vulnerable patients
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.









